Santhera Pharmaceuticals Investor Relations Material
Latest events
H2 2024
Santhera Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Santhera Pharmaceuticals Holding Ltd
Access all reports
Santhera Pharmaceuticals Holding Ltd is a biopharmaceutical company focused on developing treatments for neuromuscular and rare diseases. The company specializes in innovative therapies targeting genetic and mitochondrial disorders, aiming to address conditions with high unmet medical needs. Its research and development efforts include advancing novel drug candidates through clinical trials and regulatory approvals. The company is headquartered in Pratteln, Switzerland, and its shares are listed on the SIX Swiss Exchange.
Key slides for Santhera Pharmaceuticals Holding Ltd
H2 2024
Santhera Pharmaceuticals Holding Ltd
H2 2024
Santhera Pharmaceuticals Holding Ltd
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
SANN
Country
🇨🇭 Switzerland